These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31686421)

  • 1. Cognitive and psychiatric symptoms in genetically determined Parkinson's disease: a systematic review.
    Piredda R; Desmarais P; Masellis M; Gasca-Salas C
    Eur J Neurol; 2020 Feb; 27(2):229-234. PubMed ID: 31686421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmotor Signs in Genetic Forms of Parkinson's Disease.
    Kasten M; Marras C; Klein C
    Int Rev Neurobiol; 2017; 133():129-178. PubMed ID: 28802919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations.
    Puschmann A
    Parkinsonism Relat Disord; 2013 Apr; 19(4):407-15. PubMed ID: 23462481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review.
    Trinh J; Zeldenrust FMJ; Huang J; Kasten M; Schaake S; Petkovic S; Madoev H; Grünewald A; Almuammar S; König IR; Lill CM; Lohmann K; Klein C; Marras C
    Mov Disord; 2018 Dec; 33(12):1857-1870. PubMed ID: 30357936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Forms of Parkinson's Disease.
    Kim CY; Alcalay RN
    Semin Neurol; 2017 Apr; 37(2):135-146. PubMed ID: 28511254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
    Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
    Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Atypical' Parkinson's disease - genetic.
    Weissbach A; Wittke C; Kasten M; Klein C
    Int Rev Neurobiol; 2019; 149():207-235. PubMed ID: 31779813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapies for Genetic Forms of Parkinson's Disease: Systematic Literature Review.
    Over L; Brüggemann N; Lohmann K
    J Neuromuscul Dis; 2021; 8(3):341-356. PubMed ID: 33459660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Parkinson's disease.
    Cherian A; Divya KP
    Acta Neurol Belg; 2020 Dec; 120(6):1297-1305. PubMed ID: 32813147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of cognitive dysfunction in Parkinson's disease.
    Wise AH; Alcalay RN
    Prog Brain Res; 2022; 269(1):195-226. PubMed ID: 35248195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropathology of genetic Parkinson's disease.
    Poulopoulos M; Levy OA; Alcalay RN
    Mov Disord; 2012 Jun; 27(7):831-42. PubMed ID: 22451330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Parkinson disease.
    Domingo A; Klein C
    Handb Clin Neurol; 2018; 147():211-227. PubMed ID: 29325612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Impairment in Genetic Parkinson's Disease.
    Planas-Ballvé A; Vilas D
    Parkinsons Dis; 2021; 2021():8610285. PubMed ID: 35003622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation for monogenic Parkinson's disease: a systematic review.
    Kuusimäki T; Korpela J; Pekkonen E; Martikainen MH; Antonini A; Kaasinen V
    J Neurol; 2020 Apr; 267(4):883-897. PubMed ID: 30659355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.
    Somme JH; Molano Salazar A; Gonzalez A; Tijero B; Berganzo K; Lezcano E; Fernandez Martinez M; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2015 May; 21(5):494-9. PubMed ID: 25840672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic landscape of Parkinson's disease.
    Lunati A; Lesage S; Brice A
    Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review.
    Kasten M; Hartmann C; Hampf J; Schaake S; Westenberger A; Vollstedt EJ; Balck A; Domingo A; Vulinovic F; Dulovic M; Zorn I; Madoev H; Zehnle H; Lembeck CM; Schawe L; Reginold J; Huang J; König IR; Bertram L; Marras C; Lohmann K; Lill CM; Klein C
    Mov Disord; 2018 May; 33(5):730-741. PubMed ID: 29644727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.